Polypeptides and Methods for Enhancing and Balancing Monovalent or Multivalent Flavivirus Vaccines
Use of Vitronectin as a Biomarker for the Detection of Dengue Hemorrhagic Fever
Multiplex Assay for Detection of Dengue Virus
T24 Antigen for Diagnosing or Treating Taenia solium Cysticercosis
Entangling/Entrapping Synthetic Setae for Control of Insects and Other Pests
Novel Kinase Inhibitory Aplithianines
Summary
The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including:
Alpha-galactosidase-A Knockout Mouse Model for Studying Fabry Disease
This technology includes an alpha-galactosidase-A knockout mouse model that can be used to study Fabry disease, an X-linked lysosomal storage disorder. Alpha-galactosidase-A is a crucial enzyme responsible for the breakdown of glycolipids, particularly globotriaosylceramide (Gb3), within lysosomes. In Fabry disease, a rare and inherited lysosomal storage disorder, mutations in the GLA gene lead to deficient or non-functional alpha-galactosidase-A enzyme activity.
Moraxella Catarrhalis Lipooligosaccharide Based Conjugate Vaccines for the Prevention of Otitis Media and Respiratory Infections
Novel Kinase Inhibitory Thiazines
Summary
The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for a class of novel aplithianine-derived small molecule analogs that compete with ATP for binding on a range of clinically relevant kinases including: